Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Int J Parasitol ; 45(5): 319-32, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25720921

ABSTRACT

The obligate intracellular protozoan parasite Toxoplasma gondii interferes with major histocompatibility complex class II antigen presentation to dampen host CD4(+) T cell responses. While it is known that T. gondii inhibits major histocompatibility complex class II gene transcription and expression in infected host cells, the mechanism of this host manipulation is unknown. Here, we show that soluble parasite proteins inhibit IFNγ-induced expression of major histocompatibility complex class II on the surface of the infected cell in a dose-dependent response that was abolished by protease treatment. Subcellular fractionation of T. gondii tachyzoites revealed that the major histocompatibility complex class II inhibitory activity co-partitioned with rhoptries and/or dense granules. However, parasite mutants deleted for single rhoptries or dense granules genes (ROP1, 4/7, 14, 16 and 18 or GRA 2-9 and 12 knock-out strains) retained the ability to inhibit expression of major histocompatibility complex class II. In addition, excreted/secreted antigens released by extracellular tachyzoites displayed immunomodulatory activity characterized by an inhibition of major histocompatibility complex class II expression, and reduced expression and release of TNFα by macrophages. Tandem MS analysis of parasite excreted/secreted antigens generated a list of T. gondii secreted proteins that may participate in major histocompatibility complex class II inhibition and the modulation of host immune functions.


Subject(s)
Histocompatibility Antigens Class II/genetics , Interferon-gamma/immunology , Macrophages/immunology , Protozoan Proteins/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , Antigen Presentation , Female , Histocompatibility Antigens Class II/immunology , Host-Parasite Interactions , Humans , Male , Mice , Mice, Inbred C57BL , Protozoan Proteins/genetics , Toxoplasma/genetics , Toxoplasma/physiology , Toxoplasmosis/genetics , Toxoplasmosis/parasitology
2.
Mol Microbiol ; 81(3): 734-50, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21651628

ABSTRACT

Enterohemorrhagic Escherichia coli is a causative agent of gastrointestinal and diarrheal diseases. These pathogenic E. coli express a syringe-like protein machine, known as the type III secretion system (T3SS), used for the injection of virulence factors into the cytosol of the host epithelial cell. Breaching the epithelial plasma membrane requires formation of a translocation pore that contains the secreted protein EspD. Here we demonstrate that the N-terminal segment of EspD, encompassing residues 1-171, contains two amphipathic domains spanning residues 24-41 and 66-83, with the latter of these helices being critical for EspD function. Fluorescence and circular dichroism analysis revealed that, in solution, His6-EspD1₋171 adopts a native disordered structure; however, on binding anionic small unilamellar vesicles composed of phosphatidylserine, His6-EspD1₋171 undergoes a pH depended conformational change that increases the α-helix content of this protein approximately sevenfold. This change coincides with insertion of the region circumscribing Trp47 into the hydrophobic core of the lipid bilayer. On the HeLa cell plasma membrane, His6-EspD1₋171 forms a homodimer that is postulated to promote EspD-EspD oligomerization and pore formation. Complementation of ΔespD null mutant bacteria with an espDΔ66-83 gene showed that this protein was secreted but non-functional.


Subject(s)
Cell Membrane/metabolism , Enterohemorrhagic Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Amino Acid Sequence , Circular Dichroism , Escherichia coli Proteins/chemistry , Gene Deletion , Genetic Complementation Test , HeLa Cells , Humans , Hydrogen-Ion Concentration , Membrane Transport Proteins/chemistry , Molecular Sequence Data , Phosphatidylserines/metabolism , Protein Binding , Protein Conformation , Protein Multimerization , Sequence Alignment , Spectrum Analysis
SELECTION OF CITATIONS
SEARCH DETAIL